Briacell Therapeutics
Quarterly Financials
| Values in thousands | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -32 | -33 | -27 | -26 |
EBITDA | -12,489 | -7,174 | -7,641 | -11,638 |
EBIT | -12,522 | -7,207 | -7,668 | -11,665 |
Net Income | -12,264 | -7,164 | -7,352 | -11,489 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,946 | -7,205 | -7,967 | -10,690 |
Cash | 9,853 | 6,880 | 29,903 | 2,714 |
Basic Shares | 8,708 | 7,250 | 2,802 | 1,883 |
Annual Financials
| Values in thousands | 2026-07-31 | 2024-07-31 | 2023-07-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -117 | -82 | -15 |
EBITDA | -35,497 | -4,849 | -31,065 |
EBIT | -35,615 | -4,933 | -31,080 |
Net Income | -34,904 | -4,793 | -27,114 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -28,778 | -33,592 | -31,891 |
Cash | 9,852 | 1,196 | 28,381 |
Basic Shares | 5,010 | 1,096 | 1,041 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-07-31 | -$1.24 |
2026-04-30 | -$0.98 |
2026-01-31 | -$2.57 |
2025-10-31 | -$4.35 |